Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant Prostate Cancer Cells

Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant Prostate Cancer Cells

Novel therapeutic strategies are urgently needed for advanced metastatic prostate cancer (PCa). Phytochemicals used in Traditional Chinese Medicine seem to exhibit tumor suppressive properties. Therefore, the therapeutic potential of artesunate (ART) on the progressive growth of therapy-sensitive (p...

Full description

Bibliographic Details
Main Authors:	Olesya Vakhrusheva, Holger H. H. Erb, Vitus Bräunig, Sascha D. Markowitsch, Patricia Schupp, Patrick C. Baer, Kimberly Sue Slade, Anita Thomas, Igor Tsaur, Martin Puhr, Zoran Culig, Jindrich Cinatl, Martin Michaelis, Thomas Efferth, Axel Haferkamp, Eva Juengel
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-02-01
Series:	Frontiers in Oncology
Subjects:	prostate cancer (PCa) docetaxel (DX) resistance artesunate (ART) Traditional Chinese Medicine (TCM) growth inhibition apoptosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.789284/full

Similar Items

Artesunate Impairs Growth in Cisplatin-Resistant Bladder Cancer Cells by Cell Cycle Arrest, Apoptosis and Autophagy Induction
by: Fuguang Zhao, et al.
Published: (2020-12-01)

Artesunate Inhibits Growth of Sunitinib-Resistant Renal Cell Carcinoma Cells through Cell Cycle Arrest and Induction of Ferroptosis
by: Sascha D. Markowitsch, et al.
Published: (2020-10-01)

Shikonin Reduces Growth of Docetaxel-Resistant Prostate Cancer Cells Mainly through Necroptosis
by: Sascha D. Markowitsch, et al.
Published: (2021-02-01)

Treatment for Severe Malaria: Post-Artesunate Delayed Haemolysis and Neutropenia
by: Mariangela Martino, et al.
Published: (2022-02-01)

Tratamento da malária com artesunate (retocaps®) em crianças da Amazônia brasileira Malaria treatment with artesunate (retocaps®) in children of the Brazilian Amazon
by: Maria das Graças Costa Alecrim, et al.
Published: (2000-04-01)

Intravenous Artesunate for Severe Malaria in Travelers, Europe
by: Thomas Zoller, et al.
Published: (2011-05-01)

Post-Artesunate Delayed Hemolysis: A Review of Current Evidence
by: Sawettachai Jaita, et al.
Published: (2023-01-01)

Retinal safety and toxicity study of artesunate in vitro and in vivo
by: Bing-Wen Lu, et al.
Published: (2023-05-01)

Pre-referral rectal artesunate is no “magic bullet” in weak health systems
by: Manuel W. Hetzel, et al.
Published: (2023-03-01)

Artesunate-, sulfadoxine-, and pyrimethamine-induced cardiotoxicity
by: Divya Goel, et al.
Published: (2016-01-01)

The Other Face of Artesunate: Southern Drug to Treat Northern Diseases
by: Stephane Picot
Published: (2015-01-01)

Severe malaria in a Nigerian neonate and treatment with intravenous artesunate
by: Kelechi Kenneth Odinaka, et al.
Published: (2015-07-01)

Comparison of the efficacy of artemether-lumefantrine vs. artesunate plus sulfadoxine-pyrimethamine in children with uncomplicated falciparum malaria
by: Rachmawati Rachmawati, et al.
Published: (2010-04-01)

Activities of artesunate-based combinations and tafenoquine against Babesia bovis in vitro and Babesia microti in vivo
by: Leonardo J. M. Carvalho, et al.
Published: (2020-07-01)

Artesunate-amodiaquine versus artesunatesulfadoxine- pyrimethamine for uncomplicated falciparum malaria in children
by: Novie H. Rampengan, et al.
Published: (2014-02-01)

A Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal Cancer
by: Sanjeev Krishna, et al.
Published: (2015-01-01)

Artesunate-amodiaquine fixed dose combination for the treatment of <it>Plasmodium falciparum </it>malaria in India
by: Anvikar Anupkumar R, et al.
Published: (2012-03-01)

Stimulation of Suicidal Erythrocyte Death by Artesunate
by: Kousi Alzoubi, et al.
Published: (2014-12-01)

Preparations of Rectal Suppositories Containing Artesunate
by: Suzanne Persaud, et al.
Published: (2020-03-01)

Artesunate prevents rats from the clozapine-induced hepatic steatosis and elevation in plasma triglycerides
by: Li Y, et al.
Published: (2017-09-01)

Artesunate Suppresses the Proliferation and Development of Estrogen Receptor-α-Positive Endometrial Cancer in HAND2-Dependent Pathway
by: Xianghua Yin, et al.
Published: (2021-01-01)

Post-artesunate delayed hemolysis after treatment of malaria with intravenous artesunate: A case study
by: Abigail Foster
Published: (2022-01-01)

Synthesis and Characterization of Dimeric Artesunate Glycerol Monocaprylate Conjugate and Formulation of Nanoemulsion Preconcentrate
by: Rana Hore, et al.
Published: (2023-07-01)

Pharmacogenomic Identification of c-Myc/Max-Regulated Genes Associated with Cytotoxicity of Artesunate towards Human Colon, Ovarian and Lung Cancer Cell Lines
by: Serkan Sertel, et al.
Published: (2010-04-01)

Comparative study of efficacy of artesunate plus cotrimoxazole and artesunate plus chloroquine in the treatment of malaria in Nigerian children: a preliminary report
by: F.A. Fehintola, S.T. Balogun
Published: (2010-09-01)

Electrochemical and Theoretical Studies on the Artesunate Reduction
by: Audrey B. Silva, et al.
Published: (2020-09-01)

Artesunate Switches Monocytes to an Inflammatory Phenotype with the Ability to Kill Leukemic Cells
by: Rubia Isler Mancuso, et al.
Published: (2021-01-01)

Comparative efficacy of artesunate and sulphadoxine-pyrimethamine combination with artesunate and amodiaquine combination in uncomplicated falciparum malaria in children
by: Jose Meky Mandei, et al.
Published: (2008-08-01)

Population pharmacokinetics and pharmacodynamics of the artesunate–mefloquine fixed dose combination for the treatment of uncomplicated falciparum malaria in African children
by: Monia Guidi, et al.
Published: (2019-04-01)

Favorable outcome without corticosteroids during post-artesunate delayed hemolysis with positive direct antiglobulin test in severe imported Plasmodium falciparum malaria, France
by: Olivier Paccoud, et al.
Published: (2023-12-01)

Recent Advances in the Therapeutic Efficacy of Artesunate
by: Ngonidzashe Ruwizhi, et al.
Published: (2022-02-01)

Role of GRP78 inhibiting artesunate-induced ferroptosis in KRAS mutant pancreatic cancer cells
by: Wang K, et al.
Published: (2019-07-01)

Repurposing antimalarial artesunate for the prophylactic treatment of depression: Evidence from preclinical research
by: Shihao Huang, et al.
Published: (2023-01-01)

Predictors of health workers’ knowledge about artesunate-based severe malaria treatment recommendations in government and faith-based hospitals in Kenya
by: Beatrice Machini, et al.
Published: (2020-07-01)

Artesunate: could be an alternative drug to chloroquine in COVID-19 treatment?
by: Tuğçenur Uzun, et al.
Published: (2020-05-01)

Shikonin Inhibits Cell Growth of Sunitinib-Resistant Renal Cell Carcinoma by Activating the Necrosome Complex and Inhibiting the AKT/mTOR Signaling Pathway
by: Sascha D. Markowitsch, et al.
Published: (2022-02-01)

Evidence for the spectroscopic determination of Artesunate in dosage form
by: C.O. Esimone, et al.
Published: (2008-11-01)

The CARAMAL study could not assess the effectiveness of rectal artesunate in treating suspected severe malaria
by: James A. Watson, et al.
Published: (2023-03-01)

Plasmodium falciparum gametocyte dynamics after pyronaridine–artesunate or artemether–lumefantrine treatment
by: Johanna M. Roth, et al.
Published: (2018-06-01)

The Metabolic Changes of Artesunate and Ursolic Acid on Syrian Golden Hamsters Fed with the High-Fat Diet
by: Shichen Pu, et al.
Published: (2020-03-01)